![]() |
|||||||||||||||||||||||
|
|||||||||||||||||||||||
|
|
Product Name :
Senna Leaf Powder Extract
|
||||||||||||||||||||||
|
Senna is a shrub found in India, Pakistan, South China and elsewhere. Its name is derived from the Arabic word "sena," and it has been used in ayurvedic and unani medicines since the ninth century. The shrub grows to a height of approximately two feet, with green stems and pods and yellow, scoop-shaped leaves. The alternate leaves are even-pinnate, with four or five pairs of lanceolate or obovate leaflets that are brittle and greyish green in colour. The small yellow flowers are characterised by five spreading clawed petals. The fruit is in an oblong pod about 5cm long. The leaves and pods, or fruit, are used medicinally. History
People in northern Africa and southwestern Asia have used senna as a laxative for centuries. Senna was traditionally considered a "cleansing" herb because of its cathartic properties. More modern studies have found that senna is useful in treating constipation, whether it is caused by pharmaceuticals or natural means. In addition, the leaves were sometimes made into a paste and applied to various skin diseases. Ringworm and acne were both treated in this way. Function
The
active substances in senna leaves are called sennosides. These molecules
are converted by bacteria in the colon into another substance,
rhein-anthrone, which has two beneficial effects, colon activity
stimulation(which speeds bowel movements and improves digestion) and
increased fluid secretion. The laxative effect of sennosides and their
active metabolite, rhein anthrone, is due to inhibition of water and
electrolyte absorption from the large intestine, which increases the
volume and pressure of the intestinal contents. This will stimulate the
colon motility resulting in propulsive contractions. In addition,
stimulation of active chloride secretion increases water and electrolyte
content of the intestine. These changes in active electrolyte transport
are depend on calcium in the serosal surface. The laxative action of
Sennosides are partially via stimulation of colonic fluid and electrolyte
secretion, and this secretion is mediated by stimulation of endogenous
prostaglandin formation 2. Sennosides may be
prepared as an enema or suppository or combined with a Stool Softener or
Bulk Forming Fiber Laxative to form a Combination Laxative.3 Chemistry Senna leaf contains: Approximately 3% dianthrone glycosides (sennosides A, A1, B, C, D, E, F & G ); and small amounts of anthraquinones including aloe-emodin and rhein 8-glucoside; approximately 10% mucilage; tannins; and flavonoids. 4 The extract is standardized to 8% sennosides.This product is mainly composed of Sennosides. The structural formulas are followed:
Sennoside A: C42H38O20 Sennoside C: C42H40O19 Dosage: 100-150 mg at bedtime as purgative. 5 Safety: Sennosides
are strong purgative that should be taken with care and in proper dosage,
especially for pregnant, menstruating, or postpartum women. It cannot be
used where there is inflammation in the G.I. Tract because of irritation.
The irritant effect upon the intestinal membrane may cause griping, pain
or nausea, along with liquid stools
or diarrhea for overdose. References: 1. Muller-Lissner SA, Adverse effects of laxatives: fact and fiction, Pharmacology 1993; 47 (Supplement 1): 138-145. 2. de Witte P, Metabolism and pharmacokinetics of antrhanoids, Pharmacology 1993; 47 (Supplement 1): 86-97. 3. Steer HW and Colin-Jones DG, Melanosis coli: studies on the toxic effects of irritant purgatives, Journal of Pathology 1975; 115(4): 199-205. 4. Nusko G, et al., Melanosis coli-a harmless pigmentation or a precancerous condition?, Zeitschrift Gatroenterology 1997; 35(5): 313-318. 5. Balazs M, Melanosis coli: Ultrastructure study of 45 patients, Diseases of Colon and Rectum 1986; 29(12): 839-844. 6. Benavides SH, et al., The pigment of melanosis coli: A lectin histochemical study, Gastrointestinal Endoscopy 1997; 46(2): 131-138. 7. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. Montvale, NJ: Medical Economics, 1998, 722–4. 8. Mengs U. Reproductive toxicological investigations with sennosides. Arzneimittelforschung 1986;36:1355–8. 9. Faber P, Strenge-Hesse A. Relevance of rhein excretion into breast milk. Pharmacol 1988;36(suppl 1):212–20. |
|||||||||||||||||||||||
![]() |
|||||||||||||||||||||||